Pre-order Enquiry
Request Free Sample
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Growth (Status and Outlook) 2022-2028
SKU ID : LPI-19901297 | Publishing Date : 11-Jan-2022 | No. of pages : 120
Request Sample
Request Customization
Check Discounts
As the global economy mends, the 2021 growth of Over the Counter (OTC) Drugs & Dietary Supplements will have significant change from previous year. According to our (LP Information) latest study, the global Over the Counter (OTC) Drugs & Dietary Supplements market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Over the Counter (OTC) Drugs & Dietary Supplements market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Over the Counter (OTC) Drugs & Dietary Supplements market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Over the Counter (OTC) Drugs & Dietary Supplements market, reaching US$ million by the year 2028. As for the Europe Over the Counter (OTC) Drugs & Dietary Supplements landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Over the Counter (OTC) Drugs & Dietary Supplements players cover Pfizer Inc., Novartis International AG, Roche Holding AG, and Merck & Co., Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Over the Counter (OTC) Drugs & Dietary Supplements market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold, and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
The United States Over the Counter (OTC) Drugs & Dietary Supplements market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Over the Counter (OTC) Drugs & Dietary Supplements market, reaching US$ million by the year 2028. As for the Europe Over the Counter (OTC) Drugs & Dietary Supplements landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Over the Counter (OTC) Drugs & Dietary Supplements players cover Pfizer Inc., Novartis International AG, Roche Holding AG, and Merck & Co., Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Over the Counter (OTC) Drugs & Dietary Supplements market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold, and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
